BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 20678560)

  • 1. Sustained release coating of tablets with Eudragit(®) RS/RL using a novel electrostatic dry powder coating process.
    Qiao M; Luo Y; Zhang L; Ma Y; Stephenson TS; Zhu J
    Int J Pharm; 2010 Oct; 399(1-2):37-43. PubMed ID: 20678560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel electrostatic dry coating process for enteric coating of tablets with Eudragit® L 100-55.
    Qiao M; Zhang L; Ma Y; Zhu J; Xiao W
    Eur J Pharm Biopharm; 2013 Feb; 83(2):293-300. PubMed ID: 23183445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the film formation of the dry coating process.
    Kablitz CD; Urbanetz NA
    Eur J Pharm Biopharm; 2007 Sep; 67(2):449-57. PubMed ID: 17451928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
    Terebesi I; Bodmeier R
    Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit L 100-55.
    Sauer D; Watts AB; Coots LB; Zheng WC; McGinity JW
    Int J Pharm; 2009 Feb; 367(1-2):20-8. PubMed ID: 18848872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel electrostatic dry powder coating process for pharmaceutical dosage forms: immediate release coatings for tablets.
    Qiao M; Zhang L; Ma Y; Zhu J; Chow K
    Eur J Pharm Biopharm; 2010 Oct; 76(2):304-10. PubMed ID: 20600889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The manufacture and characterisation of hot-melt extruded enteric tablets.
    Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
    Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
    Sauer D; McGinity J
    Pharm Dev Technol; 2009; 14(6):632-41. PubMed ID: 19883252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of tetrandrine alginate calcium sustained release gel pellets].
    Ma Y; Li WZ; Chen DW
    Zhong Yao Cai; 2008 Jan; 31(1):131-4. PubMed ID: 18589765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of additives on melt viscosity, surface tension, and film formation of dry powder coatings.
    Sauer D; McGinity JW
    Drug Dev Ind Pharm; 2009 Jun; 35(6):646-54. PubMed ID: 19337869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying a novel electrostatic dry powder coating technology to pellets.
    Yang Q; Ma Y; Zhu J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):118-24. PubMed ID: 26478275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal treating as a tool to produce plastic pellets based on Eudragit RS PO and RL PO aimed for tableting.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2007 Aug; 67(1):260-7. PubMed ID: 17337169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets.
    Cerea M; Zheng W; Young CR; McGinity JW
    Int J Pharm; 2004 Jul; 279(1-2):127-39. PubMed ID: 15234801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the drug release and surface morphological properties of film-coated pellets, and physical, thermal and mechanical properties of free films as a function of various curing conditions.
    Bhattacharjya S; Wurster DE
    AAPS PharmSciTech; 2008; 9(2):449-57. PubMed ID: 18431665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aqueous film coating to reduce recrystallization of guaifenesin from hot-melt extruded acrylic matrices.
    Bruce CD; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Drug Dev Ind Pharm; 2010 Feb; 36(2):218-26. PubMed ID: 19877992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dry powder coated osmotic drug delivery system.
    Yang Q; Ma Y; Zhu J
    Eur J Pharm Sci; 2018 Jan; 111():383-392. PubMed ID: 28986194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.